test

Ron Rosenstraus

@Eversept Partners, Lp

Latest period2024 - Q3ReportedManaged Assets$1.46BTotal holdings67
Assets growth rate-0.03%Assets growth rate (2-Q avg)-1.3%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Eversept Partners, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 67 positions.

Assets under management

The assets under management (AUM) of Eversept Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.46B in assets, with a quarterly growth rate of -0.03% and a 2-quarter average growth rate of -1.3%. The portfolio is managed by Ron Rosenstraus, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
IONSIonis Pharmaceuticals Inc
Recent Activity
Increased 3.17%
1.3%
$18.882M
471,355 shares@ $40.06 avg price
VRDNViridian Therapeutics Inc
Recent Activity
Increased 21.81%
1.08%
$15.726M
691,232 shares@ $22.75 avg price
MNKDMannkind Corp
Recent Activity
Decreased -11.71%
0.86%
$12.533M
1.993M shares@ $6.29 avg price
BHCBausch Health Cos Inc
Recent Activity
New Position
0.86%
$12.492M
1.531M shares@ $8.16 avg price
TVTXTravere Therapeutics Inc
Recent Activity
Decreased -20.27%
0.84%
$12.17M
869,913 shares@ $14.0 avg price
HUMHumana Inc
Recent Activity
Decreased -10.94%
0.74%
$10.725M
33,860 shares@ $316.74 avg price
DHRDanaher Corporation
Recent Activity
Decreased -5.93%
0.74%
$10.684M
38,429 shares@ $278.03 avg price
CNCCentene Corp Del
Recent Activity
Increased 16.53%
0.7%
$10.16M
134,959 shares@ $75.29 avg price
ELVElevance Health Inc
Recent Activity
Increased 32.81%
0.7%
$10.122M
19,465 shares@ $520.0 avg price
FTREFortrea Hldgs Inc
Recent Activity
New Position
0.63%
$9.159M
457,967 shares@ $20.0 avg price